- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on TTP - Thrombotic Thrombocytopenic Purpura in Mexico
Total 19 results
-
David Gomez AlmaguerUnknownThrombotic Thrombocytopenic Purpura | Immune ThrombocytopeniaMexico
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
Hospital Universitario Dr. Jose E. GonzalezCompletedImmune Thrombocytopenic PurpuraMexico
-
Hospital Universitario Dr. Jose E. GonzalezCompletedImmune Thrombocytopenic PurpuraMexico
-
GlaxoSmithKlineCompletedPurpura, Thrombocytopaenic, IdiopathicUnited States, France, Netherlands, Spain, United Kingdom, Canada
-
Hospital Civil de GuadalajaraCompletedPrimary Immune ThrombocytopeniaMexico
-
Hospital Universitario Dr. Jose E. GonzalezCompletedIdiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, AutoimmuneMexico
-
Hospital Universitario Dr. Jose E. GonzalezUnknownImmune ThrombocytopeniaMexico
-
Novartis PharmaceuticalsRecruitingPrimary Immune Thrombocytopenia (ITP)China, United States, Spain, Singapore, Austria, Germany, Belgium, Italy, Japan, Czechia, Hong Kong, Hungary, Malaysia, Argentina, Bulgaria, Turkey, Vietnam, Australia, Thailand, Mexico, United Kingdom, France, Romania, Norway, India
-
Novartis PharmaceuticalsCompletedPurpura, Thrombocytopaenic, IdiopathicUnited Kingdom, Hong Kong, United States, Germany, Italy, Netherlands, Spain, Taiwan, Thailand, Canada, Denmark, Pakistan, Romania, Slovenia, Russian Federation, Slovakia, Sweden, Poland, China, New Zealand, Ukraine, Australia, Austria and more
-
GlaxoSmithKlineCompletedImmune Thrombocytopenic PurpuraUnited States
-
argenxActive, not recruitingPrimary Immune ThrombocytopeniaUnited States, France, Georgia, Germany, Italy, Japan, Poland, Russian Federation, Spain, Turkey, United Kingdom, Argentina, Australia, Bulgaria, Chile, China, Denmark, Greece, Ireland, Israel, Jordan, Korea, Republic of, Mexico, New... and more
-
argenxRecruitingPrimary Immune ThrombocytopeniaUnited States, Australia, Bulgaria, China, Georgia, Greece, Italy, Japan, Poland, Portugal, Romania, Russian Federation, Thailand, Turkey, Argentina, Chile, Ireland, Jordan, Tunisia, Korea, Republic of, Mexico, New Zealand, South Africa and more
-
AmgenCompletedImmune ThrombocytopeniaUnited States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
-
TakedaActive, not recruitingPrimary Immune ThrombocytopeniaSpain, United States, Croatia, Italy, China, Germany, Bulgaria, Greece, Slovenia, Japan, Ukraine
-
Principia Biopharma, a Sanofi CompanyRecruitingImmune ThrombocytopeniaUnited States, China, Argentina, Australia, Brazil, Canada, France, Hungary, Israel, Korea, Republic of, Mexico, Russian Federation, Singapore, Spain, Thailand, United Kingdom, Austria, Chile, Germany, Italy, Japan, Netherlands, Norway and more
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeCanada, United States, Japan, France, Spain, Mexico, Peru, Brazil, New Zealand, Belgium, China, Germany, Hungary, Israel, Italy, Poland, South Africa, Turkey, India
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingAtypical Hemolytic Uremic SyndromeUnited States, Belgium, China, France, Spain, Canada, South Africa, Japan, Brazil, Italy, Poland, India, Hungary, Mexico, Israel
-
Novartis PharmaceuticalsRecruitingAtypical Hemolytic Uremic SyndromeChina, Korea, Republic of, Austria, Taiwan, Greece, Czechia, United States, Japan, Brazil, United Kingdom, India, Slovakia, Slovenia